NCT01794793 2024-10-01Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored StudiesRECORDATI GROUPPhase 4 Completed337 enrolled 8 charts
NCT01789281 2021-06-11Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.NovartisPhase 4 Completed34 enrolled 8 charts
NCT01525550 2019-07-30A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine TumorsPfizerPhase 4 Completed106 enrolled 26 charts